This document discusses coronary perforation, which occurs when there is extravasation of contrast medium or blood from the coronary artery during or following a percutaneous coronary intervention. Coronary perforations are classified based on location and severity. Risk factors include older age, previous CABG, device-lumen mismatch, oversized balloons, calcification, and chronic total occlusions. Treatment depends on the type and severity of perforation, ranging from conservative measures like balloon inflation, to covered stents or surgery for more severe perforations involving cardiac tamponade. Covered stents help seal the perforation but have limitations including reduced flexibility.
Although the risks of coronary angiography have declined over the years by increased clinical experience and advanced technologies, it still requires attention, knowledge and experience due to being an interventional diagnostic method. A safe coronary angiography begins with the selection of the appropriate catheter for the anatomical structure of the patient and the evaluation of the pressure when the catheter is placed in the coronary ostium. Coronary pressure waves are complementary requirements of angiography. The recognition, evaluation and precautions to be taken for abnormal pressure waves directly affect the mortality of the patient. One of the first clues to the presence of stenosis in the left main coronary artery (LMCA) is abnormal changes in pressure when the catheter is seated in the ostial LMCA. This often occurs as a “ventricularization” or “damping”. For decades, ventricularization was mostly experienced as a stenosis by invasive cardiologists [1]. Recognition of abnormal changes in pressure and precautions to be taken prevent catastrophic outcomes in patients
https://crimsonpublishers.com/ojchd/fulltext/OJCHD.000518.pdf
For more open access journals in Crimson Publishers
please click on https://crimsonpublishers.com/
For more articles in open journal of Cardiology & Heart Diseases
please click on https://crimsonpublishers.com/ojchd/
rotablation is procedure used in complex pci with heavily calcified lesion for adequate expansion of stent.if used in indicated case and well aware of contraindication is necessary for achieving good results.
Although the risks of coronary angiography have declined over the years by increased clinical experience and advanced technologies, it still requires attention, knowledge and experience due to being an interventional diagnostic method. A safe coronary angiography begins with the selection of the appropriate catheter for the anatomical structure of the patient and the evaluation of the pressure when the catheter is placed in the coronary ostium. Coronary pressure waves are complementary requirements of angiography. The recognition, evaluation and precautions to be taken for abnormal pressure waves directly affect the mortality of the patient. One of the first clues to the presence of stenosis in the left main coronary artery (LMCA) is abnormal changes in pressure when the catheter is seated in the ostial LMCA. This often occurs as a “ventricularization” or “damping”. For decades, ventricularization was mostly experienced as a stenosis by invasive cardiologists [1]. Recognition of abnormal changes in pressure and precautions to be taken prevent catastrophic outcomes in patients
https://crimsonpublishers.com/ojchd/fulltext/OJCHD.000518.pdf
For more open access journals in Crimson Publishers
please click on https://crimsonpublishers.com/
For more articles in open journal of Cardiology & Heart Diseases
please click on https://crimsonpublishers.com/ojchd/
rotablation is procedure used in complex pci with heavily calcified lesion for adequate expansion of stent.if used in indicated case and well aware of contraindication is necessary for achieving good results.
preop TEE assessment of atrial septal defect is very important for making decision for device closure, properly assessed adequate rims of ASD will reduce risk of device embolization to almost nil.
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
preop TEE assessment of atrial septal defect is very important for making decision for device closure, properly assessed adequate rims of ASD will reduce risk of device embolization to almost nil.
This is a comprehensive description of coronay lesion assessment from routinely used angiography to advanced imaging modalities like IVUS/OCT including their functional significance by FFR
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Coronary perforation
1. CORONARY PERFORATION
Definition- Evidence of extravasation of contrastmedium or blood from
the coronary artery during or following percutaneous intervention.
Anatomically classifiedas:-
1) Proximal/ mid vessel
- Usually more profound with greater likelihood of significant
sequelae.
-
2) Distal vessel
- Etiology is often guide wire (WIRE EXIT).
- Clinical courseis frequently benign
Other classification
Fukutomi
Type 1- Epicardial staining without a contrast extravasation.
Type 2- Epicardial staining with a visible jet of contrast extravasation.
Kini
Type 1 – Myocardial staining without contrast extravasation
2. Type 2- Contrast extravasation into pericardium, coronary sinus or cardiac
chambers.
Incidence
0.5%
Complication rate:-
◦ POBA -0.1%
◦ Excimer laser -1.9%
◦ Rotational atherectomy – 1.3%
Lesion prone for perforation
CTO (27%)
Calcification
Tortuosity
Eccentric plaque
Bifurcation lesion
AHA/ACC class B/C lesion
Small calibre vessel (<2.5mm)
Patient relatedrisk factors
Older age
Previous CABG
Lower creatinine clearance
Other risk factors
Device-lumen mismatch
Oversized compliant balloons (Balloon to artery ratio>1.2).
High inflation pressure
In case of perforation, GP 11b-111a inhibitors, is a/w
- Higher incidence of tamponade
- Greater requirement of emergency surgery.
3. - Guidewires
Hydrophilic wire more prone for CAP
More likely to cause distally, in the terminal sub-branches
Less likely to cause frank rupture than a high pressure balloon
barotrauma
most of the guide wire mediated rupture is Ellis type1 or type 2
Prevention- create loop at the end of the wire.
Prevention
Keep ACT optimum
IIIa-IIb use when indication is must
UFH is preferable to Bivaluridin in complicated cases becauseeasy
reversal with protamine
Multiple views
Dual injections
Delayed watch
4. Start with workhorse wire or hydrophilic tipped/ stiff wires that are used
to get through difficult lesions should be exchanged for workhorse wires
with softer hydrophobic tips
IVUS
Confine wire to true lumen
Do not dilate in side branch or collaterals
Supportive measures:-
I/V fluids
Oxygen
Analgesia
Ionotropic support
Atropine
IABP
Type 1 perforation treatment
Usually respond to conservative measures.
Close monitoring
Serial echocardiography
5. Repeated injections of contrastmedia every 15-30 minutes
No further action is required if degree of extravasation does not increase
or diminishes.
Increased extravasation is treated with reversal of anticoagulation and/or
prolonged balloon inflation at or proximal to the perforated segment.
Type 2/3 perforation
Proximal/ mid vessel- Inflate balloon at the site of bleeding.
Balloon inflation for upto 30 minutes usually at 2 atm
If patient cannot tolerate ischemia (uncommon in CTO–PCIdue to
presence of collaterals), then perfusion balloon can be used.
Microcatheter over another guide wire is positioned distal to site of
perforation and the patient's own arterial blood via microcatheter is
injected (microcatheter distal perfusion technique).
Anticoagulation- If the procedureis to be discontinued, reversalof
heparin with protamine has shown to be effective. (But this should be
deferred till balloons & wires are still in the artery.
Antiplatelet
GPI should be discontinued bcoz even trivial blush of extravasation may
progress to severeproblem with this use.
Abciximab bind irreversibly to platelet receptors, leading to platelet
activity almost negligible for 24-36 hrs.
Platelet transfusion may be required.
However, in caseof tirofiban & eptifibatide, simply discontinuing the
infusion is sufficient .
Cardiac tamponade
Urgent echo & pericardiocentesis.
If there is no resolution of bleeding at 30 minutes, further action is
required including surgery.
6. If the bleeding frompericardial tube is persistat a rate of 10mlper
minute, despite mechanical & pharmacologicalaction, surgery is
indicated.
Measurein deploying covered stent- Deployed at high pressure(14-16
atm) with prolonged balloon inflation to allow optimal stent expansion –
to ensure sealing of perforation & to reducethe risk of stent thrombosis
1) JOSTENTGraftMaster
Stainless steel stent covered with polytetrafluoroethylene (PTFE)
Wall thickness - 0.3mm
Size - 3.0 to 5.0.
Minimum Guiding catheter 6 to 7 F
Bulkier than other covered stents
2) In situDirect stentstent-graft
Stainless steel PTFE covered stent.
Wall thickness 0.15mm
Thinnest covered stent available (starting at 1.2mm.
7. Size – 2.5mmto 6.0mm
Minimum Guiding catheter 6 to 7 F
3) Over & Under pericardiumcoveredstent
Stainless steel stent covered with equine pericardium (105 um
thickness).
Highly flexible
Size- 2.5 to 4.0mm
More biocompatible, less risk of stent thrombosis.
4) PK Papyrus coveredcoronary stent
Cobalt chromium stent covered with polyurethane(90um thickness)
Highly flexible with low crossing profile.
Size- 2.5 to 5.0mm
Guiding catheter- 5 to 6Fr
Low crossing profilereduces the stiffness of crimped stent graftby upto
58%
Limitation of covered stents
Bulkier than normal stents
Reduced flexibility & trackability.
Increserisk of stent thrombosis (5.7%)& restenosis (29%)
Dual guiding catheter technique
Aim– to reduce the time between deflation of sealing balloon & final delivery
of the covered stent at the perforation site
Steps-
Sealing ballon is infalted
Guide catheter is withdrawn slightly from coronary ostia
Another guiding catheter (7Fr/8Fr) inserted from C/L femoral artery &
engage the samecoronary ostia.
8. Covered stent graft(or coil in case of smaller & distal vessel) is
advanced on a new wire via second guide catheter & placed just
proximal to the sealing balloon.
Sealing balloon is deflated & withdrawn proximally to allow passageof
wire & covered stent which is to be deployed
Sealing balloon, wire & guide catheter is removed only after gaining
adequate seal of the lesion with covered stent